Literature DB >> 8479707

Extraocular muscle involvement in sarcoidosis.

W T Cornblath1, V Elner, M Rolfe.   

Abstract

BACKGROUND: Sarcoidosis is a granulomatous inflammatory disease that may have a variety of ocular and orbital manifestations. The most common ocular manifestation is uveitis, and the most common orbital manifestation is dacryoadenitis. Extraocular muscle involvement in sarcoidosis has rarely been reported. The authors report a case of sarcoidosis involving the extraocular muscles of a 15-year-old boy with bilateral, painful, external ophthalmoplegia and enlargement of all extraocular muscles on computed tomography (CT) scan.
RESULTS: Lateral rectus muscle biopsy and transbronchial lung biopsy showed noncaseating granulomas characteristic of sarcoidosis. Cultures and serologic studies excluded fungal and mycobacterial diseases. Treatment with oral corticosteroids improved symptoms and signs.
CONCLUSIONS: The authors report the first case of sarcoidosis in a patient with symptomatic extraocular muscle involvement, and only the third case in which extraocular muscle involvement has been shown histologically.

Entities:  

Mesh:

Year:  1993        PMID: 8479707     DOI: 10.1016/s0161-6420(93)31615-5

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

1.  Normative measurements of inferior oblique muscle thickness in Japanese by magnetic resonance imaging using a new technique.

Authors:  Maria Suzanne Sabundayo; Hirohiko Kakizaki; Yasuhiro Takahashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-01-19       Impact factor: 3.117

2.  Masquerading Orbital Sarcoidosis with Isolated Extraocular Muscle Involvement.

Authors:  Jane S Kim; Richard L Scawn; Bradford W Lee; Jonathan H Lin; Bobby S Korn; Don O Kikkawa
Journal:  Open Ophthalmol J       Date:  2016-04-29

3.  Atypical clinical presentation of isolated extraocular muscle sarcoid.

Authors:  Wing Lung Alvin So; Thomas G Hardy; Penelope McKelvie
Journal:  Case Rep Ophthalmol Med       Date:  2012-12-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.